All Industries

Top healthtech Companies

659 healthtech companies, sorted by total funding raised.

Harmony BiosciencesIPO

Commercial-stage pharmaceutical company focused on developing and commercializing innovative ther...

Plymouth Meeting, United States201–500healthtech, Biotech
Venture Unknown·$295.0M·Jan 2018
Inspire Medical SystemsIPO

Medical technology company that develops and markets the Inspire implant, an FDA-approved neurost...

Golden Valley, United States1001–5000Healthcare, healthtech
Private Equity·$287.0M·Aug 2022
AbSciIPO

Generative AI drug creation platform for designing and developing biologics

Vancouver, United States201–500Artificial Intelligence, Biotech
Growth Equity·$279.5M·Aug 2025
Beta Bionics, Inc.IPO

R&D company with 4 SBIR/STTR awards from Department of Defense, Department of Health and Human Se...

Boston, United States11–50Digital Health, Healthcare
Series E·$275.6M·Nov 2024
Nuvation Bio Inc.IPO

Global oncology company focused on developing therapies to tackle the toughest challenges in canc...

New York, United States51–200healthtech, biotech
Series A·$275.0M·Oct 2019
Tectonic TherapeuticIPO

Clinical-stage biotechnology company focused on the discovery and development of therapeutic prot...

Watertown, United States51–200healthtech, Biotech
Private Equity·$265.0M·Feb 2025
SepternaIPO

Clinical-stage biotechnology company pioneering GPCR drug discovery through its proprietary Nativ...

South San Francisco, United States51–200Biotechnology, healthtech
Series B·$250.0M·Jul 2023
Vir BiotechnologyIPO

Clinical-stage biotech developing antibody- and T-cell engager-based therapeutics for infectious ...

San Francisco, United States201–500Biotech, Drug Discovery
Growth Equity·$250.0M·Oct 2024
Inhibrx BiosciencesIPO

Clinical-stage biopharmaceutical company developing targeted immunotherapy candidates for life-th...

La Jolla, United States51–200healthtech, Biotech
Private Equity·$250.0M·Aug 2023
Rapport TherapeuticsIPO

Clinical-stage biopharmaceutical company focused on the discovery and development of precision sm...

Boston, United States11–50healthtech, Biotech
Series B·$250.0M·Aug 2023
Sophia GeneticsIPO

AI-driven platform that analyzes genomic, radiomic, and multimodal healthcare data for hospitals,...

Lausanne, Switzerland201–500Artificial Intelligence, Data & Analytics
Series F·$245.8M·Oct 2020
Agios PharmaceuticalsIPO

Commercial-stage biopharmaceutical company developing therapies for rare hematologic diseases by ...

Cambridge, United States501–1000Biotech, Healthcare
Series C·$241.0M·Nov 2011
Ionis PharmaceuticalsIPO

Pioneer in RNA-targeted medicine developing treatments for serious diseases with few or no existi...

Carlsbad, United States1001–5000healthtech, Biotech
Corporate Round·$235.2M·Apr 2021
Tango TherapeuticsIPO

Clinical-stage biotechnology company discovering novel drug targets and delivering precision canc...

Cambridge, United States51–200healthtech, Biotech
Series C·$235.0M·May 2025
Shattuck LabsIPO

Shattuck Labs is a clinical-stage biotechnology company developing novel biologic therapies targe...

Austin, United States51–200healthtech, biotech
Corporate Round·$221.0M·Aug 2025
MeiraGTx Holdings plcIPO

MeiraGTx Holdings is a vertically integrated, clinical-stage genetic medicines company developing...

New York, United States51–200healthtech, Biotech
Corporate Round·$220.0M·Apr 2026
Assembly BiosciencesIPO

Biotechnology company developing antiviral treatments for hepatitis B, hepatitis delta, and herpe...

South San Francisco, United States51–200healthtech, biotech
Venture Unknown·$217.7M·Aug 2025
PharvarisIPO

Pharvaris is a clinical-stage company focused on the discovery and development of treatments for ...

Zug, Switzerland51–200Life Sciences, Biotech
Private Equity·$216.0M·Jun 2023
Connect BiopharmaIPO

Clinical-stage biopharmaceutical company developing therapies for inflammatory diseases including...

San Diego, United States51–200Biotech, Immunology
Corporate Round·$215.2M·Mar 2026
CVRxIPO

Rheos Baroreflex Hypertension Therapy System for treatment of refractory hypertension

Minneapolis51–200medical devices, neuromodulation
Venture Unknown·$205.6M·Jul 2020
Disc MedicineIPO

Clinical-stage biopharmaceutical company discovering and developing novel treatments for hematolo...

Watertown, United States51–200healthtech, Biotech
Venture Unknown·$202.5M·Feb 2023
SpyGlass PharmaIPO

Medical device incubator focused on three novel ophthalmic devices.

Aliso Viejo, United StatesBiotech, Healthcare
Series D·$199.2M·Jun 2025
NeuroPaceIPO

Developing implantable devices for the treatment of neurological disorders by responsive brain st...

Mountain View, United States201–500Hardware, Healthcare
Extension Round·$198.1M·Aug 2020
Recursion Pharmaceuticals, LLCIPO

R&D company with 5 SBIR/STTR awards from Department of Health and Human Services.

Salt Lake City, United States1–10healthtech
Series C·$196.1M·Jul 2019
SchrodingerIPO

Physics-based computational platform for drug discovery and materials science research used by ph...

New York, United States1001–5000Artificial Intelligence, Healthcare
Series E·$195.0M·May 2019